Alluvi Retatrutide 20mg
For labs running initial Retatrutide studies or working with smaller participant pools, the 20mg vial format offers a practical entry point into one of the most consequential metabolic research compounds currently available.
Oxford Peptide Innovations stocks Alluvi Healthcare Retatrutide 20mg directly — verified, batch-documented, and dispatched from within the UK.
The Case for Alluvi Retatrutide 20mg in Your Research
Retatrutide research is growing fast, and not every study requires the 40mg format. The Alluvi Retatrutide 20mg vial is suited to:
- Pilot studies establishing baseline parameters before scaling
- Comparative mechanistic research requiring lower-strength controls
- Labs with smaller research budgets without compromising on quality
Whatever the study design, Alluvi Healthcare’s manufacturing standards mean the 20mg vial delivers the same purity and traceability as the 40mg format — just at a lower quantity.
Each vial is:
- Manufactured by Alluvi Healthcare to high-purity standards
- Supplied as a lyophilized (freeze-dried) powder for stability
- Batch-tested and sealed before dispatch
- Supplied with full traceability documentation
- For research and development use only
Alluvi Retatrutide 40mg Pen — The Next Step Up
If your research requires a higher-strength or pre-filled format, see our Alluvi Retatrutide 40mg pen listing or the Synedica Retatrutide 40mg pen for an alternative manufacturer option.
Retatrutide: Where the Research Stands
Triple agonist. GIP, GLP-1, glucagon. Published Phase 2 data reporting up to 24% average weight reduction at 48 weeks. The compound is drawing researchers from across metabolic, endocrine, and obesity biology — and the published data keeps building.
For background reading before sourcing:
Provided for scientific context only. Not medical advice.
Storage
- Refrigerate at 2–8°C or freeze for long-term storage
- Keep away from direct light and moisture
- Sterile reconstitution technique required
- Follow standard peptide-handling protocols after reconstitution
Research Use Only
This product is sold strictly for laboratory R&D. Not for human or animal consumption. Not a medicine or supplement. Not MHRA or FDA evaluated for therapeutic use. For qualified researchers in appropriate settings only. Purchasers must be 18+.
Related Products
- Alluvi Retatrutide 40mg Pen
- Synedica Retatrutide 40mg Pen
- Alluvi Tirzepatide 40mg
- Full Peptide Range
FAQ
Is Alluvi Retatrutide 20mg available in the UK? Yes — stocked and dispatched by Oxford Peptide Innovations from within the UK.
What’s the difference between 20mg and 40mg Retatrutide? Quantity per vial. For higher-strength options, see our Alluvi Retatrutide 40mg pen.
Is this suitable for human use? No. R&D use only.
Related products
ALLUVI
ALLUVI
ALLUVI
ALLUVI